Abdominal Aortic Aneurysm Treatment Market By Type of treatment 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Abdominal Aortic Aneurysm Treatment Market
Abdominal Aortic Aneurysm Treatment Market Analysis: By Type of treatment (Surgery, Medication); By Location of treatment (Hospitals and Clinics) – With Forecast (2016-2021)
Report Code : HCR 0107
Published: 25 January, 2016   No. of pages: 133

  • Report Description
  • Table of Contents
  • Customization Options
The enlargement of lower part of aorta in the abdomen is termed as Abdominal aortic aneurysm. Should there be a rupture in the abdominal aortic, aneurysm may cause abnormal bleeding. This leads to internal bleeding which is otherwise known as haemorrhaging. The treatment for such a case is dependent on the location of the haemorrhaging as well as the size of the enlargement.  The condition normally takes place in individuals over 60 years of aged. Smoking, high cholesterol, high blood pressure are just come of the factors that lead to abdominal aortic aneurysm.

Although abdominal aortic aneurysm takes place in individuals over the age of 60, there are cases taking place in individuals in the age range of 40 – 50 as well although very few. This number will tend to increase in the coming years if individuals do not make any changes to their lifestyle. The current lifestyle of people is one of the main reasons as to why abdominal aortic aneurysm takes place.

In terms of incidence, North America has the highest percentage of abdominal aortic aneurysm and is expected to remain the highest contributor till the end of the forecast period. There is however investment in R&D across the globe for the development of drugs for abdominal aortic aneurysm which will add to the growth of the market during the forecast period.

Abdominal Aortic Aneurysm Treatment Market

The Abdominal Aortic Aneurysm market can be segmented based on type of treatment Surgery, Open surgery, Endovascular aneurysm, Medication, Antihypertensive, Antilipidemics. The Abdominal Aortic Aneurysm market has been segmented based on the location of where the treatments can take place, Hospitals and Clinics. The market has been segmented based on the following geographies. North America, South America, APAC, Europe, Middle East and Africa.

Following is a small list of companies that are changing the landscape of the abdominal aortic aneurysm:
  • Abbott
  • AbbVie
  • Amgen
  • Bristol-Myers
  • Celgen Corporation
1. Abdominal Aortic Aneurysm Treatment – Market Overview
2. Executive Summary
3. Abdominal Aortic Aneurysm Treatment – Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User Profiling
      3.2.3. Top 5 Financials Analysis
4. Abdominal Aortic Aneurysm Treatment – Market Forces
   4.1. Market Drivers
   4.2. Market Constraints
   4.3. Market Challenges
   4.4. Attractiveness of the Abdominal Aortic Aneurysm Treatment Market
      4.4.1. Power of Suppliers
      4.4.2. Power of Customers
      4.4.3. Threat of New Entrants
      4.4.4. Threat of Substitution
      4.4.5. Degree of Competition
5. Abdominal Aortic Aneurysm Treatment Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Abdominal Aortic Aneurysm Treatment Market– By type of treatment:
   6.1. Surgery
      6.1.1. Open Surgery
      6.1.2. Endovascular Aneurysm repair
   6.2. Medication
      6.2.1. Antihypertensive
      6.2.2. Antilipidemics
7. Abdominal Aortic Aneurysm Treatment Market– By location of treatment
   7.1. Hospitals
   7.2. Clinics
8. Abdominal Aortic Aneurysm Treatment Market– By Geography:
   8.1. Introduction
   8.2. Global Study
   8.3. Americas
      8.3.1. North America
      8.3.2. Brazil
      8.3.3. Argentina
      8.3.4. Others
   8.4. Europe
      8.4.1. U.K.
      8.4.2. France
      8.4.3. Germany
      8.4.4. Others
   8.5. APAC
      8.5.1. China
      8.5.2. Japan
      8.5.3. India
      8.5.4. Others
   8.6. ROW
9. Abdominal Aortic Aneurysm Treatment Market Entropy
   9.1. New Product Launches
   9.2. M&As, Collaborations, JVs and Partnerships
10. Company Profiles
   10.1. Abbott
   10.2. AbbVie
   10.3. Amgen
   10.4. Bristol-Myers
   10.5. Celgen Corporation
   10.6. GlaxoSmithKline Pharmaceuticals Limited
   10.7. Merc & Co
   10.8. Mylan N.V.
   10.9. Novartis Pharmaceuticals
   10.10. Pfizer
   10.11. Sanofi
   10.12. Teva pharmaceutical Industries
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix

   11.1. Abbreviations
   11.2. Sources
   11.3. Research Methodology
   11.4. Bibliography
   11.5. Compilation of Expert Insights
   11.6. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports